Appendix cancer is rare — roughly 1 to 2 cases per million people per year. That rarity is exactly why research has lagged behind other cancers for decades. Major cancer registries lump appendiceal cases in with colorectal cancer or miss them entirely. Insurance claims data captures billing codes, not biology. Hospital records sit in silos, locked to the institution that holds them.

What that means in practice: when a researcher tries to answer a basic question — does this drug work for HAMN? or what survival rate should a goblet cell adenocarcinoma patient actually expect? — they often cannot find enough cases to draw a confident answer. The data is out there. It is just not in one place.

A patient-led, patient-controlled registry solves that. It pools the lived experience of patients across institutions, geographies, and treatment paths into a single dataset. It does not replace hospital records. It augments them — adding the patient voice, the long-tail outcomes, the quality-of-life details, and the treatment decisions that never made it into a chart note.

The APPENDICURE registry is structured to capture the data that researchers and clinicians actually need to move appendix cancer science forward. You control what you share. Nothing is published without your permission.

For most of medical history, a rare disease meant a slow disease — slow to be understood, slow to be treated, slow to find drugs that actually worked. The math was unforgiving: too few patients, too little data, not enough signal to justify the cost of research.

Artificial intelligence is rewriting that math. AI models do not need millions of cases to find a pattern. They can detect signals in datasets that are too small, too messy, or too scattered for traditional statistics. They can connect appendix cancer biology to drugs that already exist for other diseases. They can flag the subtypes that respond differently to treatment. They can compress decades of trial-and-error into months of computation.

That is not science fiction. It is happening right now — including for appendix cancer specifically. But every one of those AI tools needs the same thing to work: data. Patient data, cleaned and structured and consented and pooled. The registry is how we make sure appendix cancer is in the dataset when the next generation of AI tools gets built.